SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

India may impose anti-dumping duty on Chinese antibacterial drug Ciprofloxacin Hydrochloride

17 Jun 2020 Evaluate

India may impose anti-dumping duty on Chinese antibacterial drug Ciprofloxacin Hydrochloride, with a view to guard domestic players from cheap imports from the neighbouring country. Aarti Drugs had filed the application for imposition of anti-dumping duty on imports of the medicine from China. Ciprofloxacin Hydrochloride is used to treat different types of bacterial infections, including skin infections, bone and joint infections, respiratory or sinus infections, urinary tract infections, and certain types of diarrhea. It acts as anti-infective agent, and an antibacterial drug.

After conducting a probe, the commerce ministry's investigation arm, Directorate General of Trade Remedies (DGTR), in its preliminary findings has recommended imposition of provisional anti-dumping duty on the product from China. The duty recommended is in the range of $0.94 per kg to $3.29 per kg.

The directorate in a notification said that in its probe, it has concluded the product has been exported to India by Chinese firms at dumped prices and due to this the domestic industry has suffered material injury. The authority recommends imposition of provisional anti-dumping duty so as to remove the injury to the domestic industry. While DGTR recommends the duty, the finance ministry takes the final decision to impose the duty.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×